NCT00551343View on ClinicalTrials.gov

Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Prader-Willi Syndrome
Interventions
DRUG

Exenatide

10ug Exenatide single s.c. injection

Trial Locations (1)

2010

Garvan Institute of Medical Research, Sydney

Sponsors
All Listed Sponsors
lead

Garvan Institute of Medical Research

OTHER

NCT00551343 - Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome | Biotech Hunter | Biotech Hunter